Schuster-Bruce James, Sargent Pippa, Madden Brendan, Ofo Enyinnaya, Allin David
Department of Ear, Nose and Throat, Head and Neck Surgery, St George's University Hospitals NHS Trust, London, UK.
Department of Medicine, St George's University Hospitals NHS Trust, London, UK.
Clin Otolaryngol. 2022 May;47(3):414-423. doi: 10.1111/coa.13923. Epub 2022 Apr 5.
Locally aggressive thyroid cancer can result in airway obstruction secondary to tracheal compression or vocal cord palsy. A tracheal stent provides an alternative to surgical resection, tracheostomy or conservative management in patients with compressive symptoms. This systematic review synthesises the current evidence associated with tracheal stenting in locally advanced thyroid cancer.
DESIGN, SETTING AND PARTICIPANTS: We conducted a systematic review of tracheal stenting in locally advanced thyroid cancers. We searched MEDLINE, Embase and Web of Science for studies until 22 September 2020. Inclusion criteria were studies involving patients who had received tracheal stents to treat laryngotracheal stenosis secondary to locally advanced thyroid cancer. Single case reports or single cases were not included.
We assessed studies for data on the performance of tracheal stenting; defined as symptomatic relief, spirometry data, complication rates and mortality. We also extracted data pertaining to the use of different types of stent.
We identified eight full-text articles from 325 titles found in our search. These were all single-centre retrospective studies that lacked homogeneity of thyroid cancer histotypes. The number of patients in each study ranged from 4 to 35 patients. Stenting improved performance status (two of two studies), symptoms (five of five studies) and spirometry (two of three studies). The most common complications were tracheal granulation, tumour overgrowth, stent migration and sputum retention.
There is a lack of evidence in the literature of tracheal stents in locally advanced thyroid cancer. However, the evidence available suggests tracheal stenting may be a useful treatment adjunct in advanced thyroid cancer-causing symptomatic airway obstruction.
局部侵袭性甲状腺癌可导致气管受压或声带麻痹继发气道梗阻。对于有压迫症状的患者,气管支架可作为手术切除、气管造口术或保守治疗的替代方案。本系统评价综合了与局部晚期甲状腺癌气管支架置入相关的现有证据。
设计、设置和参与者:我们对局部晚期甲状腺癌气管支架置入进行了系统评价。我们检索了MEDLINE、Embase和科学网,检索截至2020年9月22日的研究。纳入标准为涉及接受气管支架治疗局部晚期甲状腺癌继发喉气管狭窄患者的研究。不包括单例报告或单个病例。
我们评估了有关气管支架置入性能数据的研究;定义为症状缓解、肺功能测定数据、并发症发生率和死亡率。我们还提取了与不同类型支架使用相关的数据。
我们从搜索到的325篇标题中确定了8篇全文文章。这些都是单中心回顾性研究,缺乏甲状腺癌组织学类型的同质性。每项研究中的患者人数从4人到35人不等。支架置入改善了功能状态(两项研究中的两项)、症状(五项研究中的五项)和肺功能测定(三项研究中的两项)。最常见的并发症是气管肉芽形成、肿瘤过度生长、支架移位和痰液潴留。
文献中缺乏局部晚期甲状腺癌气管支架的证据。然而,现有证据表明气管支架置入可能是晚期甲状腺癌导致症状性气道梗阻的一种有用的治疗辅助手段。